Literature DB >> 33585204

Silencing of Long Non-Coding RNA LINC00607 Prevents Tumor Proliferation of Osteosarcoma by Acting as a Sponge of miR-607 to Downregulate E2F6.

Yuehuan Zheng1,2,3, Zhe Chen2, Zezhu Zhou4, Xiangyang Xu2,3, Huilin Yang1.   

Abstract

Osteosarcoma (OS), a type of malignant bone tumor, is commonly found in children and adolescents. Although previous studies have identified that long non-coding RNAs (lncRNAs) regulate OS, it is unclear whether lncRNAs impact the progression of OS. Here, we identified LINC00607, a lncRNA that facilitates OS proliferation, migration, and invasion. Based on the RNA-sequencing results, LINC00607 expression was significantly upregulated in pulmonary metastasis within OS. Functional experiments revealed that LINC00607 promoted migration and invasion of endothelial cells to exacerbate epithelial-mesenchymal transition (EMT). Furthermore, the results of RNA pull-down assay and invasion assay suggested that the binding between LINC00607 and miR-607 promoted OS invasion. Bioinformatic analysis and rescue experiments demonstrated that E2F6, a transcriptional factor, functioned downstream of LINC00607/miR-607. Finally, we found that LINC00607 promoted OS progression in vivo. This work revealed that LINC00607 worked as an miR-607 sponge to upregulate E2F6 expression, which promoted tumor proliferation in OS. These results identified a novel therapeutic target for treating OS.
Copyright © 2021 Zheng, Chen, Zhou, Xu and Yang.

Entities:  

Keywords:  E2f6; LINC00607; lncRNA; miR-607; osteosarcoma

Year:  2021        PMID: 33585204      PMCID: PMC7877452          DOI: 10.3389/fonc.2020.584452

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  45 in total

1.  E2F6 negatively regulates ultraviolet-induced apoptosis via modulation of BRCA1.

Authors:  W-W Yang; Z-H Wang; Y Zhu; H-T Yang
Journal:  Cell Death Differ       Date:  2006-11-10       Impact factor: 15.828

2.  Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.

Authors:  Stefan S Bielack; Beate Kempf-Bielack; Günter Delling; G Ulrich Exner; Silke Flege; Knut Helmke; Rainer Kotz; Mechthild Salzer-Kuntschik; Matthias Werner; Winfried Winkelmann; Andreas Zoubek; Heribert Jürgens; Kurt Winkler
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

Review 3.  Long Noncoding RNA in Cancer: Wiring Signaling Circuitry.

Authors:  Chunru Lin; Liuqing Yang
Journal:  Trends Cell Biol       Date:  2017-12-20       Impact factor: 20.808

4.  Incidence and survival of malignant bone sarcomas in England 1979-2007.

Authors:  Jeremy Whelan; Anne McTiernan; Nicola Cooper; Yuen K Wong; Matthew Francis; Sally Vernon; Sandra J Strauss
Journal:  Int J Cancer       Date:  2011-11-02       Impact factor: 7.396

Review 5.  lincRNAs: genomics, evolution, and mechanisms.

Authors:  Igor Ulitsky; David P Bartel
Journal:  Cell       Date:  2013-07-03       Impact factor: 41.582

6.  Height at diagnosis and birth-weight as risk factors for osteosarcoma.

Authors:  Lisa Mirabello; Ruth Pfeiffer; Gwen Murphy; Najat C Daw; Ana Patiño-Garcia; Rebecca J Troisi; Robert N Hoover; Chester Douglass; Joachim Schüz; Alan W Craft; Sharon A Savage
Journal:  Cancer Causes Control       Date:  2011-04-05       Impact factor: 2.506

7.  The long noncoding RNA LUCAT1 promotes tumorigenesis by controlling ubiquitination and stability of DNA methyltransferase 1 in esophageal squamous cell carcinoma.

Authors:  Jung-Ho Yoon; Bo-Hyun You; Chan Hyuk Park; Yeong Jin Kim; Jin-Wu Nam; Sang Kil Lee
Journal:  Cancer Lett       Date:  2017-12-14       Impact factor: 8.679

8.  Long non-coding RNA MALAT1 for promoting metastasis and proliferation by acting as a ceRNA of miR-144-3p in osteosarcoma cells.

Authors:  Yong Wang; Yueyang Zhang; Tao Yang; Wei Zhao; Ningning Wang; Pengcheng Li; Xiandong Zeng; Weiguo Zhang
Journal:  Oncotarget       Date:  2017-07-31

Review 9.  Long Noncoding RNA (lncRNA)-Mediated Competing Endogenous RNA Networks Provide Novel Potential Biomarkers and Therapeutic Targets for Colorectal Cancer.

Authors:  Liye Wang; Kwang Bog Cho; Yan Li; Gabriel Tao; Zuoxu Xie; Bin Guo
Journal:  Int J Mol Sci       Date:  2019-11-16       Impact factor: 5.923

10.  Small and Long Non-Coding RNAs: Novel Targets in Perspective Cancer Therapy.

Authors:  Chi Han Li; Yangchao Chen
Journal:  Curr Genomics       Date:  2015-10       Impact factor: 2.236

View more
  3 in total

1.  Vascular Regulation by Super Enhancer-Derived LINC00607.

Authors:  Kiran Sriram; Yingjun Luo; Dongqiang Yuan; Naseeb Kaur Malhi; Alonso Tapia; Vishnu Amaram Samara; Rama Natarajan; Zhen Bouman Chen
Journal:  Front Cardiovasc Med       Date:  2022-06-28

2.  Identification of a circRNA-miRNA-mRNA regulatory network for exploring novel therapeutic options for glioma.

Authors:  Yi He; Yihong Chen; Yuxin Tong; Wenyong Long; Qing Liu
Journal:  PeerJ       Date:  2021-08-06       Impact factor: 2.984

3.  Circular RNA hsa_circ_0003823 promotes the Tumor Progression, Metastasis and Apatinib Resistance of Esophageal Squamous Cell Carcinoma by miR-607/CRISP3 Axis.

Authors:  Yu-Ming Wang; Qi-Wu Zhao; Zhi-Yong Sun; Hai-Ping Lin; Xin Xu; Min Cao; Yu-Jie Fu; Xiao-Jing Zhao; Xiu-Mei Ma; Qing Ye
Journal:  Int J Biol Sci       Date:  2022-09-21       Impact factor: 10.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.